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Abstract
Falls are a leading cause of death in the elderly and, in a majority of patients with Parkinson’s disease (PD), the leading
levodopa-insensitive cause of hospitalization and long-term care. Falling in PD has been attributed to degeneration of forebrain
cholinergic neurons that, in interaction with striatal dopamine losses, impairs the cognitive control of balance, gait, and movement.
We previously established an animal model of these dual cholinergic–dopaminergic losses (“DL rats”) and a behavioral test sys-
tem (Michigan Complex Motor Control Task, MCMCT) to measure falls associated with traversing dynamic surfaces and distrac-
tors. Because the combined treatment of the acetylcholinesterase inhibitor donepezil and the 5-HT6 receptor antagonist
idalopirdine (Lu AE58054) was reported to exhibit synergistic pro-cholinergic activity in rats and improved cognition in patients
with moderate Alzheimer’s disease, here we assessed the effects of this treatment on MCMCT performance and attention in DL
rats. Compared with the vehicle-treated group, the combined treatment greatly reduced (Cohen’s d = 0.96) falls in DL rats when
traversing dynamic surfaces and when exposed to a passive distractor. However, falls associated with a dual task distractor and
sustained attentional performance did not benefit from this treatment. Analyses of the behavior in fall-prone moments suggested
that this treatment improved the efficacy and speed of re-instating forward movement after relatively short stoppages. This treat-
ment may reduce fall propensity in PD patients via maintaining planned movement sequences in working memory and improving
the vigor of executing such movements following brief periods of freezing of gait.
Introduction
In addition to the disease-characterizing motor symptoms that reflect
primarily striatal dopamine loss, Parkinson’s disease (PD) is charac-
terized by widespread neurodegenerative processes in non-dopami-
nergic brain systems. Degeneration of non-dopaminergic systems
has been associated with autonomic, behavioral, and cognitive
symptoms, including a propensity for falls, which do not benefit
from levodopa treatment. The role of non-dopaminergic circuits and
how they interact with nigrostriatal circuit loss to cause levodopa-
unresponsive symptoms remains poorly understood, posing a critical
barrier to the development of therapies for these disabling symptoms
(Wood, 2002; Balash et al., 2005; Langston, 2006).
Although multiple cognitive and motor risk factors increase the
probability for falls, impairments in the attentional supervision of
movement are a major contributing factor for falls, specifically when
unfamiliar surfaces and obstacles or secondary tasks challenge gait,
balance, and movement control (Brown et al., 1999; Woollacott &
Shumway-Cook, 2002; Hausdorff et al., 2006; Yogev-Seligmann
et al., 2008; Allcock et al., 2009; LaPointe et al., 2010; Theill
et al., 2011). Gait, balance, and movement errors normally evoke
compensatory attentional control. However, as the disease process
also impacts the brain’s attention systems, such compensatory
deployment of attentional resources is increasingly unavailable for
rescuing movement and preventing falls. Consistent with this view,
degeneration of a major attention system of the brain, the basal fore-
brain (BF) cholinergic projections to telencephalic and thalamic
regions, but not losses of basal ganglia dopamine, correlate with
low gait speed, freezing of gait, and falls in PD patients (Bohnen &
Albin, 2009; Bohnen et al., 2009, 2013; Yarnall et al., 2011).
The specific cognitive-behavioral consequences of combined BF
cholinergic and striatal dopamine losses are not well understood.
Accumulating evidence supports the notion that the cholinergic sys-
tem mediates the detection of cues in attentional contexts and the
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goal-directed deployment of attention resources (Parikh et al., 2007;
Howe et al., 2013; Sarter et al., 2014b, 2016; Gritton et al., 2016).
Thus, as a result of cholinergic loss, the cortical processing of cues
is impaired and thus cue-based information, such as those that signal
movement errors or imbalance, is not effectively transferred to the
striatum. Striatal dopamine loss, in general terms, yields impair-
ments in action selection and sequencing, and decreases in move-
ment vigor and velocity (e.g., Gepshtein et al., 2014; Rueda-Orozco
& Robbe, 2015; Yttri & Dudman, 2016). Thus, combined choliner-
gic–dopaminergic losses have been hypothesized to render striatal
circuitry largely incapable of integrating information about ongoing
behavior which, in interaction with poor habitual action control,
gives rise to major gait and balance errors, ineffective movement
recovery after errors, and thus falls (Sarter et al., 2014a; Pelosin
et al., 2016).
We recently described a rat model of falls resulting from dual BF
cholinergic and striatal dopaminergic losses (“DL rats”) and from
the attentional taxation of gait, balance, and complex movement. DL
rats combine bilateral cortical cholinergic and partial striatal
dopaminergic deafferentation, produced by intracranial infusions of
neurotoxins (192 IgG-saporin and 6-hydroxydopamine, respectively).
The extent of the cholinergic lesions in these animals has been
informed by results from PET imaging studies that indicated moder-
ate decreases in cortical and thalamic cholinergic input in PD
patients with a history of falls (Bohnen et al., 2009). Striatal dopa-
mine lesions have targeted the prefrontal projection field in the dor-
somedial caudate nucleus, reflecting our goal to determine
interactions between dopamine loss and the impact of loss of cholin-
ergic deafferentation of primarily prefrontal regions on striatal func-
tion (for more discussion of this model see Sarter et al., 2014a).
Falls in DL rats have been characterized using a newly designed
behavioral test system, the Michigan Complex Motor Control Task
(MCMCT) that involves a progressively demanding series of traver-
sal conditions (e.g., stationary planks and rods; rotating beams; dis-
tractors). Compared to rats with single lesions and sham-lesioned
controls, DL rats exhibit a propensity for falls. As in patients, risk
factors for falls in this rat model involves dynamic surfaces, expo-
sure to distractors, relatively slow gait speed, postural instability,
and micropauses during forward movement. Furthermore, falls in
DL rats correlate with impairments in sustained attentional task
(SAT) performance (Kucinski et al., 2013, 2015a; Sarter et al.,
2014a; Kucinski & Sarter, 2015), further indicating that this animal
model reproduces falls caused by interactions between impairments
in attention and movement control.
Here we employed this animal model and the associated behav-
ioral test system (MCMCT) to assess the potential therapeutic effi-
cacy of the combined treatment with the acetylcholinesterase
(AChE) inhibitor donepezil (DON) and the 5-HT6 receptor antago-
nist idalopirdine (IDL). Co-treatment with DON and IDL was found
to significantly improve the cognitive abilities of patients with mod-
erate Alzheimer’s disease in a phase II trial (Wilkinson et al.,
2014). The neuronal mechanisms underlying the interactions
between these two drugs remain unclear but may involve synergistic
pro-cholinergic effects and associated elevations in telencephalic
high-frequency oscillations (Herrik et al., 2016).
In the present experiment, DON and IDL were administered sepa-
rately and together to DL rats performing the MCMCT and the
SAT. Compared with control and vehicle-treated DL rats, single
drug treatments did not improve performances. In DL rats given
both drugs, fall rates were significantly reduced, except for those
evoked by a dual task situation. Unexpectedly, decreases in fall rates
were not associated with improved SAT performance. Together, the
evidence suggests that dual treatment with an acetylcholinesterase
inhibitor and a 5-HT6 receptor antagonist may reduce falls that are
associated with relatively brief periods of freezing of gait and with
slow and low-vigor re-initiation of movement.
Materials and methods
Subjects
Adult male and female Sprague–Dawley rats (Harlan; N = 70; 35
males and 35 females) between 3 and 6 months of age were individ-
ually housed in opaque single standard cages
(27.70 cm 9 20.30 cm) in a temperature- and humidity-controlled
environment (23 °C, 45%). Throughout the experiment, male rats
weighed more than females (F1,69 = 460.29, P < 0.001; males:
359.86 + 4.27 g females: 249.24 + 2.48 g), but weights did not dif-
fer across experimental groups (main effect of group and
sex 9 group: both F < 0.29, both P > 0.88). The animals were
maintained under a 12:12 h light/dark schedule (lights on at 8:00
AM). Food (Rodent Chow; Harlan Teklad) was available ad libitum.
Water access was gradually restricted over a 7-day period (12, 8, 5,
3, 1, 0.5, 0.25 h of water access per day) in the week before pre-
and post-surgery behavioral testing. During testing, water was pro-
vided as rewards for correct responses during SAT performance and
following beam traversals on the MCMCT (see below). Rats were
also provided water ad libitum for 15 min following SAT perfor-
mance each day (ad libitum water was not given following the after-
noon MCMCT sessions). All procedures were conducted in
adherence with protocols approved by the University Committee on
Use and Care of Animals at the University of Michigan and in labo-
ratories accredited by the Association for Assessment and Accredita-
tion of Laboratory Animal Care.
Timeline of experiments
Animals were initially trained on the SAT (~ 2 months of daily
training; ~ 9:00–11:00 AM). Upon reaching the final stage of train-
ing animals remained on this stage for 14 consecutive days. During
the final 6 days of training, rats were also trained on the MCMCT
in the afternoons (~ 2:00–4:00 PM). Previous experiments showed
that performance on either task was unaffected when rats were
trained on both tasks on the same day (Kucinski et al., 2013). Fur-
thermore, because we previously demonstrated that rats’ circadian
rhythm entrain to daily SAT practice, yielding a robust diurnal phe-
notype (Paolone et al., 2012; Gritton et al., 2013), all behavioral
testing likely occurred during the animals’ active phase of the day.
Following pre-surgery training, animals underwent stereotaxic
lesion surgeries followed by 4 weeks of recovery. During the final
week of recovery animals were gradually water restricted. Drug
effects were then assessed over 12 consecutive days of SAT and
MCMCT sessions (see Table 1 for the battery of MCMCT test con-
ditions). Drug or vehicle injections were administered 30 min prior
to SAT sessions (~ 9:30 injections, SAT testing 10:00–10:45 AM)
and in the afternoon before MCMCT testing (~ 3:30–6:00 PM). For
the MCMCT runs, rats were injected individually so that trials
began exactly 30 min after injection for each animal.
Michigan Complex Motor Control Task (MCMCT)
Complex movement performance measures including fall propensity
were assessed using the MCMCT (for details and an illustration see
Kucinski et al., 2013). This beam traversal apparatus was designed
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to tax the ability of rats to perform attention-demanding movements
and correct for stepping errors while crossing a narrow square rod
surface (2.54 cm2). The ends of the beam (2.0 m length) were held
in sockets that allowed the rod to be rotated by a gear motor (10
RPM) coupled to one end of the beam element. Traversal of the
rod, particularly when rotating, reliably generated falls and other
movement impairments in rats with dual lesions of striatal dopamin-
ergic and cortical cholinergic inputs (Kucinski et al., 2013; Kucinski
& Sarter, 2015). A flat plank surface (13.3 cm wide) was also used
to assess basic motor capacity and for habituation to the apparatus.
Two identical platforms (23.0 9 31.5 cm area) situated at the oppo-
site ends of the beam were surrounded by retractable walls (27.0 cm
height) to form end-box structures. The walls are raised and lowered
manually and secured in position by a friction clamp which rides in
a vertical slot in the support structure under the platform. The walls
facing the beam had openings (9.0 cm wide) to allow rats to enter
and leave the end-boxes. Copper water cups (2.7 cm diameter, 3 cm
deep) were embedded on the floors of the end-boxes and rats were
provided with ~ 150 lL of water following each traversal. These
rewards were intended as an incentive for self-initiated traversals
and thus limited experimenter handling during testing.
At the beginning of a test session, rats were placed on the rod or
plank ~ 10 cm from an end-box and allowed to enter the box and
drink the water rewards. Once inside the box on the first trial, and
in subsequent trials, rats were given ~ 45 s to drink the water and
explore. Rats were able to leave the end-boxes to traverse to the
opposite side of the beam at any time. If after 45 s the rats did not
initiate traversal, the walls were lowered as cues to begin traversal.
The majority of rats self-initiated traversal when the walls were low-
ered, however, if not, the rats were moved to the plank or rod by
the experimenter. When falls occurred, animals fell into a safety net
(0.7 9 0.2 m) section of a badminton net (generic) placed 20 cm
below the beam element. The net frame also served as a mounting
point for the various cameras, mirrors, and distractor elements.
Falls, slips, and traversal time were assessed as described previ-
ously (Kucinski et al., 2013). A fall was scored in the following
instances: when slip/missteps caused a rat to stop forward movement
and lose upright walking posture resulting in the underside of the
animal hitting the surface of the rod, when the rat fell completely
off the rod onto the netting below the rod or hung from the rod by
its paws, and when a rat ceased forward movement and clung to the
rod while it rotated (thus rotating upside down with it). A slip was
scored when any of the rats’ paws lost contact with the surface of
the rod and extended below the lower horizontal border of the rod.
Traversal time was defined as the latency to traverse the entire dis-
tance of the beam. During trials in which a fall occurred, slips and
traversal time were prorated by multiplying the ratio of the distance
of a full traversal to the distance where the hind limbs lost contact
with the rod during the fall.
Two distractors were presented during traversals. First, a passive
doorframe distractor, comprised of a 46.0 9 39.4 cm surface with
a doorframe shape cutout of 20 cm 9 10 cm made of foam core,
was incorporated into the MCMCT test sequence. The distractor
was placed at the midway point along the beam (100 cm mark) with
side jambs 3.5 cm from the rod surface on both sides and the top
border of the doorframe cutout 11 cm above the flat rod surface.
We previously found that this distractor caused movement disrup-
tions such as freezing of gait and falls (Kucinski et al., 2013,
2015b; Kucinski & Sarter, 2015), therefore modeling the effects of
such distractor in PD patients (Cowie et al., 2012). Second, animals
were tested with an active distractor task in which a water reward
(three drops of water; ~ 150 lL) was presented on a platform
(4.9 cm diameter) during traversals. The platform was also placed at
the 100 cm mark, with 2–3 cm separating the rod and the platform.
Rats were first acclimated to the task in four shaping trials (test
days 8 and 9). In these trials, rats were placed directly on the sta-
tionary (non-rotating) rod adjacent to the platform (approximately
midway across the beam) and allowed to drink the water from the
platform. After shaping trials, rats underwent four test trials in
which the rats performed unassisted traversals of the rotating rod
(alternating directions) with presentations of water rewards. In two
other test days (10 and 12), rats performed 10 test runs per day
(Table 1). In addition to falls, the number of water rewards earned,
defined as licking/drinking water from the platform for ≥ 1 s, were
counted. All trials were recorded using a system of four bullet
cameras (KT&C; model KPCS190SH Black/White Bullet Camera
Table 1. MCMCT testing sequence







6 Rod cc 6
Post-surgery sequence
1 Plank 6
2 Rod Stationary 6
3 Rod cc 6
4 Rod cw 6
5 Rod cc-cw-cc-cw-cc-cw 6
6 Rod cc-cw-cc-cw-cc-cw Doorframe distractor 6 (3 with doorframe)
7 Rod cc-cw-cc-cw-cc-cw Doorframe distractor 6 (3 with doorframe)
8 Rod cc-cw-cc-cw Active distractor 8 (4 shaping; 4 test trials)
9 Rod cc-cw-cc-cw Active distractor 8 (4 shaping; 4 test trials)
10 Rod cc-cw-cc-cw-cc-cw-cc-cw-cc-cw Active distractor 10
11 Rod cc-cw-cc-cw-cc-cw-cc-cw-cc-cw Doorframe distractor 10 (6 with doorframe)
12 Rod cc-cw-cc-cw-cc-cw-cc-cw-cc-cw Active distractor 10
cc, cw, counterclockwise, clockwise.
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with 1/3” SONY Super HAD CCD) with rotatable bases that were
fastened to the outer support frame of the outer side of the apparatus
by hand clamps. Performance measures were analyzed by video
playback by experimenters blind to the lesion status and treatment
regimen of the rats.
Sustained Attention Task
Apparatus
Training and testing were conducted using 12 operant chambers
(MED Associates Inc.) housed within individual sound-attenuating
cubicles. Each chamber was equipped with two retractable levers, a
central panel white light (2.8 W), and a water dispenser located on
the same wall as the panel lights. The water dispenser was capable
of administering 45 lL of water per delivery. Signal presentation,
lever operation, reinforcement delivery, and data collection were
controlled by a Pentium PC and Med-PC for Windows software
(version 4.1.3; MED Associates).
Acquisition
Water-deprived rats were initially trained to press a lever for a water
reward in accordance with a modified fixed ratio-1 (FR1) schedule
for water reinforcement. During this phase of training, any lever
press resulted in the delivery of water. Typically, the animals do not
exhibit a side bias with regard to which lever is pressed; however, if
one lever was pressed five times in succession, the FR1 schedule
was modified to require the animal to press the opposite lever before
the next reward can be obtained. After 3 consecutive days with 120
reinforced lever presses each, the rats began training to discriminate
between a signal (1 s illumination of the central panel light) and a
non-signal (no illumination) event. Two seconds (s) after a signal or
non-signal event, both levers were extended into the operant cham-
ber and remain extended for 4 s or until a lever was pressed. If no
press occurred after 4 s, the levers retracted and an omission was
scored. Immediately following responses (either correct or incorrect),
both levers were retracted and the variable intertrial interval (ITI;
12  3 s) was reset. On signal trials, a press of the left lever was
reinforced and termed a “hit,” whereas a press of the right lever was
not reinforced and termed a “miss.” On non-signal trials, a press of
the right lever was reinforced and termed a “correct rejection,”
whereas a press of the left lever was not reinforced and termed a
“false alarm.”
Animals received water rewards only for correct responses
(45 lL for each hit and correct rejection), whereas incorrect
responses (misses and false alarms) were not rewarded. To eliminate
the possibility of a selection bias, half of the animals were trained
with the opposite pattern. Signal and non-signal events were pre-
sented in pseudorandom order for 81 trials each (total of 162 trials)
per session. During this phase of training, incorrect responses were
followed by correction trials in which the previous trial was
repeated. After three consecutive incorrect responses on correction
trials, the animal underwent a forced trial in which the lever was
extended for 90 s or until the animal made a response. If the forced-
choice trial was a signal trial, the signal light remained illuminated
for as long as the lever was extended. The house light was not illu-
minated during this training stage. Animals progressed to the subse-
quent step of shaping if they responded correctly to ≥ 70% of both
signal and non-signal trials for three consecutive days.
During the third phase of shaping, multiple signal durations (500,
50, and 25 ms) were introduced and the ITI was reduced to
9  3 s. Correction and forced-choice trials were also eliminated.
Trial type and signal duration were pseudorandomly determined for
each trial. Session length was set at 40 min. After at least 3 days of
stable performance, defined by at least 70% hits to 500 ms signals,
70% correct rejections, and ≤ 30% omissions, animals began train-
ing in the final version of the task. The final version was identical
to the previous training stage except that the house light was illumi-
nated throughout the session. The addition of the illuminated house
light represents a crucial element of testing sustained attention as it
requires the animal to constrain its behavior and focus on the central
panel light during task performance. Upon reaching the final stage
of training prior to lesion surgeries, animals remained at this stage
for 14 consecutive days and scores from the final 5 days of perfor-
mance were averaged to determine pre-surgery scores for each ani-
mal. During post-surgery testing of drug effects, rats were tested
only on the final stage for 12 consecutive days and scores from the
final 5 days were once again averaged for final analyses.
Measures of Sustained Attentional Task performance
The following behavior measures were recorded during each SAT
session: hits, misses, false alarms, correct rejections, and omissions.
Misses and false alarms are the inverse of hits and correct rejections,
respectively. The relative number of hits (hits/hits + misses) for each
signal length as well as the relative number of correct rejections (cor-
rect rejections/correct rejections + false alarms) were calculated. In
addition, an overall measure of attentional aptitude, the SAT score,
that integrates both the relative number of hits (h) and the relative
number of false alarms (f), was also determined at each signal dura-
tion. The SAT score was calculated using the following formula:
(hf)/[2(h + f)(h + f)²] (Frey & Colliver, 1973). Thus, SAT scores
are not confounded by errors of omission. SAT scores ranged from
1.0 to 1.0, with 1.0 indicating that all responses were hits and cor-
rect rejections, 0 indicating an inability to discriminate between signal
and non-signal events, and 1.0 indicating that all responses were
misses and false alarms. Errors of omission were recorded separately.
Lesions
Of the 70 rats, 56 (28 females and 28 males) received dual striatal
dopaminergic, cortical cholinergic system lesions (DL) and were
randomly assigned to four treatment conditions after surgeries
(n = 14/group, 7/sex). Fourteen rats (7/sex) received sham lesions.
Rats were first placed in vaporization chambers and anesthetized
with 4–5% isoflurane (delivered at 0.6 L/min O2 using a SurgiVet
Isotec 4 Anesthesia Vaporizer) until the animals were no longer
responsive to a tail pinch and exhibited no hind limb withdrawal
reflex. The animals’ heads were shaved using electric clippers and
cleaned with a betadine scrub. The animals were then mounted to a
stereotaxic instrument (David Kopf Instruments) and isoflurane anes-
thesia was maintained at 1–3% for the remainder of the surgery. An
approximately 2.5 cm incision was made down the midline of the
scalp to expose the skull. The animals’ body temperature was main-
tained at 37 °C using Deltaphase isothermal pads (Braintree Scien-
tific). Ophthalmic ointment was provided for lubrication of the eyes.
To prevent hypovolemia and hemodynamic instability during pro-
longed surgeries, 1 mL/100 g 0.9% of NaCl (s.c.) was administered.
Animals also received an injection of an analgesic (Carprofen;
5.0 mg/kg; s.c) prior to surgery and once or twice daily as necessary
for 48 h post-operatively.
6-OHDA was delivered bilaterally to dopamine terminals in the
dorsal striatum (Sigma-Aldrich; 6.0 lg/2 lL/infusion, bolus;
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dissolved in 0.9% NaCl with 0.1% ascorbic acid; two infusion sites
per hemisphere: AP + 1.2 and + 0.2 mm; ML  2.5 and  3.0 mm
relative to bregma; DV 4.8 and 5.0 mm from skull). Desipra-
mine hydrochloride (10 mg/kg; i.p.; Sigma-Aldrich) was adminis-
tered to rats receiving 6-OHDA infusions 30 min prior to surgeries
for protection of noradrenergic neurons (Breese & Traylor, 1971).
Basal forebrain cholinergic neurons situated in the nucleus basalis
and substantia innominate were targeted with immunotoxin 192
IgG-saporin (Advanced Targeting Systems) in aCSF infused bilater-
ally (120 ng/lL; 0.5 lL/hemisphere; AP 0.8; ML  2.9; DV
7.8). Sham rats received equal volumes of 0.9% NaCl with 0.1%
ascorbic acid (striatum) and aCSF (basal forebrain) without neuro-
toxins. Following infusions, the needle was left in position for 5–
10 min to foster absorption of the toxins. Non-absorbable sutures
were used to close the incisions and a topical antibiotic (Neosporin)
was applied to the wounds immediately after surgery.
Drug administration and groups and justification of drug doses
The acetylcholinesterase inhibitor donepezil (DON; 0.3 mg/kg; pro-
vided by Lundbeck) and the 5-HT6 receptor antagonist idalopirdine
(IDL; Lu AE58054; 5.0 mg/kg; Lundbeck) were dissolved in 5% 2-
hydroxypropyl-beta-cyclodextrin (HP-beta-CD) vehicle solution.
Rats were divided into the following drug administration groups (14
per group, 7/sex): sham-lesioned and administered vehicle
(SH/VEH), DL and vehicle (DL/VEH), DL and donepezil (DL/
DON), DL and idalopirdine (DL/IDL), and DL and idalopirdine plus
donepezil (DL/DON + IDL). Solutions were prepared the night
before administration and were replaced every 6 days. DON and IDL
were dissolved in the same solution for the combination treatment.
Rats were injected s.c. (2.0 mL/kg) at four alternating injection sites
(left neck, right flank, right neck, left flank; sequence repeated). Rats
were injected 30 min prior to performing the SAT in the morning
and 30 min prior to performing the MCMCT in the afternoon.
Drug doses were selected based on data from a pilot experiment
that assessed, in four DL rats each, the effects of DON alone, at
0.1, 0.3, and 1.0 mg/kg, or administered in combination with IDL
(5.0 mg/kg). Results suggested that MCMCT performance of DL
rats may benefit most clearly from the treatment combination involv-
ing the middle dose of DON.
Histology and assessments of lesions
Following the completion of post-surgery drug testing, rats were
deeply anesthetized and transcardially perfused at a rate of
50 mL/min with 0.1 M phosphate buffer solution (PBS) for 2 min
followed by perfusion with 4% paraformaldehyde in 0.4 M Na-phos-
phate solution and 15% picric acid (pH 7.4) for 9 min. Brains were
rapidly removed and post-fixed for 2–6 h at 4 °C and then rinsed in
0.1 M PBS and stored in 30% sucrose solution and allowed to sink.
Coronal sections (40 lM thickness) were sliced using a freezing
microtome (CM 2000R; Leica) and stored in antifreeze solution.
Tyrosine hydroxylase (TH) and ChAT immunostains were per-
formed as previously described (Kucinski et al., 2013; Kucinski &
Sarter, 2015).
TH-immunostained sections were imaged at 49 magnification
using a Leica DM400B digital microscope. SPOT 5.1 software (Spot
Imaging Solutions) was used to capture images. Two sections
(AP + 1.2 and + 0.2 mm) were used to generate a single score
depicting the size and degree of bilateral lesions. 6-OHDA infusions
were targeted to the dorsal striatum centered between the medial
and lateral boundaries. The lesion size was rated based on the size
of the area of TH loss observed in the dorsal striatum, with a score
of 10 corresponded to 100% of the dorsal striatum exhibiting TH
loss, a score of 5–50%, and a score of 1–10%. The extent of TH
clearance (degree of TH loss) within the lesion size area was also
determined based on a scale of 1–10, with a rating of 10 corre-
sponding to complete depletion of TH within the lesion space, and
lower values corresponding to the percent of TH remaining (e.g., 5
is 50% TH loss, 2 is 20% TH loss). Scores for lesion size and
extent were averaged from both sections and hemispheres to yield a
single lesion score for each rat.
To assess the extent of cholinergic cell losses, semi-quantitative
estimates of the number of cholinergic neurons were generated, as
done previously (Kucinski et al., 2013; Kucinski & Sarter, 2015).
Photographs of the ChAT-stained basal forebrain of the two hemi-
spheres were taken at 59 magnification using a Leica DM400B dig-
ital microscope. Cell count estimates were taken from the area of
the nucleus basalis of Meynert (nbM) and substantia innominata (SI)
within a 680 lm 9 680 lm region, and from the horizontal nucleus
of the diagonal band/preoptic area within a 1000 lm 9 1300 lm
region. For each rat, one section at about Bregma 0.8 mm (AP)
was used to generate a cholinergic cell estimate. The “count” func-
tion Photoshop CS6 was used to quantify the number of ACh cells.
This feature also tags each neuron already counted to prevent dou-
ble-counts and allows for review by a second counter. These semi-
quantitative estimates from the two hemispheres were averaged to
yield a single estimate of residual cholinergic cells per rat. To deter-
mine the relationships between the degree of lesions and measures
of performance and to verify that all DL lesion groups had compara-
ble lesions, a single composite score, reflecting the severity of the
two system lesions, was generated for each rat. For this purpose,
cholinergic cell loss of two basal forebrain areas per hemisphere
were rated from 5 to 1 (5: > 90% cell loss relative to control; 4:
> 80%; 3: > 70%; 2: > 60%; 1: > 30–50% loss). This score multi-
plied by 2 was averaged with the TH lesion score described above
to generate a single composite score (out of 10) per DL rat.
Statistical analyses
SAT and MCMCT performance measures were compared between
the five groups and primarily using within-subjects repeated-mea-
sures ANOVAs as well as one- or two-way ANOVAs when applicable.
Sex was a factor in all analyses. The analysis of SAT scores and
hits also included the within-subject factor signal duration (500, 50,
and 25 ms). For MCMCT runs on the rod (test days 2–5), traversal
time, slips, and falls were assessed using condition (stationary, rotat-
ing counterclockwise (cc) or clockwise (cw), or rotating in alternat-
ing directions) as a within-subjects factor. For each condition (or
day), performance measures were averaged over each rats’ 6 runs
on that day and these averaged values were used for statistical anal-
yses. On doorframe test days (6, 7, and 11), falls evoked by the
doorframe distractor were compared between groups and sexes. Falls
and rewards obtained during the active distractor condition were
compared using two-way ANOVAs. Comparisons of doorframe-evoked
freeze behavior and other performance measures between DL/VEH
and DL/DON + IDL rats were carried out using two-way ANOVAs.
Two-way ANOVAs were also used to compare TH/ChAT composite
lesion scores between the drug groups and sexes. Following signifi-
cant main effects, post hoc multiple comparisons were conducted
using the least significant difference (LSD) test. Significant interac-
tions between the effects of group and other factors were followed
by one-way ANOVAs on the effects of group and LSD multiple com-
parison tests. Statistical analyses were performed using SPSS for
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Windows (version 17.0: SPSS). In cases of violation of the sphericity
assumption, Huyhn–Feldt-corrected F- values, along with uncor-
rected degrees of freedom, are given. Alpha was set at 0.05. Exact
P values are reported as recommended previously (Greenwald et al.,
1996). Variances are reported and illustrated as standard error of the
mean (SEM). Effect sizes for selected effects are reported using
Cohen’s d (Cohen, 1988).
Results
Pre-surgery Sustained Attentional Task and MCMCT
performance
Prior to surgery, rats underwent SAT training until they reached
stable criterion performance and they were also familiarized with the
MCMCT. Rats required 27–55 (range) practice sessions/days to
reach SAT criterion performance and practiced the SAT for at least
an additional 14 sessions before being assigned to one of the five
experimental groups prior to surgery. Performance data from the
final five pre-surgery sessions were averaged. There were no sex
effects on any measure of performance (SAT score, hits, correct
rejections, omissions: all F < 0.38, all P > 0.51; SAT scores across
signal durations: 0.29  0.16; hits across signal duration:
48.26  1.53%, correct rejections: 79.78  1.22%, omissions:
1.34  0.23%). Rats were then evenly distributed into five drug
groups based on the SAT scores, with seven rats per sex in each
group. Groups were then randomly assigned to treatment conditions.
SAT performance did not differ between these groups prior to sur-
gery (all F < 1.16, all P > 0.34) nor were there any interactions
between group, sex, and signal duration (all F < 1.16, all P > 0.15).
Pre-surgery familiarization with the MCMCT involved 3 days of plank
traversal training followed by 2 days on the stationary (non-rotating) rod
and, on day 6, the rotating rod (counterclockwise [cc] direction only;
Table 1). Performances on the rotating rod trials were analyzed. During
this first exposure to the rotating rod, rats on average fell twice across the
six trials and these falls occurred primarily during the initial runs (1st run:
53% of all rats fell; 6th run: 16%). Sex did not affect traversal time
(3.91  0.12 s), the number of slips (1.60  0.09), or the percentage of
falls (32.86  2.09%; all F < 1.40, all P > 0.24). Comparisons between
the groups indicated statistically similar MCMCT performance levels
prior to surgery (all F < 1.23, all P > 0.31).
DON + IDL reduced fall rate in DL rats
On the first day of MCMCT testing, rats performed traversals of the
plank surface. This surface rarely causes slips or falls, therefore only
traversal time was assessed. Traversal time did not differ between
groups and sexes (main effects and interaction: all F < 1.46, all
P > 0.23; 4.02  0.16 s per traversal; see Table 2 for an overview
of major statistical findings from this study).
On days 2, 3, 4, and 5 (Table 1), rats performed traversals with
the rod surface and were assessed for traversal time as well as slips
and falls (six traversals per day, 24 total runs). On day 2, the rod
remained stationary (non-rotating) followed by rotation of the rod
(10 RPM) in the familiar counterclockwise (cc) direction on day 3.
On day 4, the rod’s direction was reversed to the unfamiliar clock-
wise (cw) direction and on day 5, the direction of rotation was alter-
nated between successive trials (cc-cw-cc-cw-cc-cw). Performance
measures were analyzed for the effects of group, sex, and testing
condition (stationary rod, cc, cw, alternating) as the within-subjects
factor.
Falls
Rotation of the rod generally increased the number of falls across
all animals (main effect of testing condition: F3,180 = 6.48,
P < 0.001; falls from stationary rod: 21.67  1.90%, cc:
32.62  1.90%, cw: 30.00  2.34%, alternating: 30.00  2.00%;
less falls on stationary rod than all other conditions (all P < 0.001).
Across these trials, a main effect of group on fall frequency
(F4,60 = 2.62, P = 0.04) reflected that compared with the frequency
of falls in DL/VEH rats, SH/VEH, and DL/DON + IDL rats fell sig-
nificantly less frequently (Cohen’s d = 0.96; for multiple compar-
isons see Fig. 1A). Furthermore, and in contrast to DL/DON + IDL
rats, with a fall frequency that was statistically similar to that seen
in SH-VEH rats, rats treated only with IDL fell as frequently as
untreated DL rats (DL/VEH). The frequency of falls in DL/DON
rats tended to be lower than in DL/VEH rats but the effect did not
reach significance (P = 0.17). The effects of group and testing con-
dition did not interact (F12,180 = 1.00, P = 0.45) indicating that all
performance across all rod conditions contributed to the demonstra-
tion of the large (as indicated by d) treatment effect by DON + IDL.
There was no sex effect and no interactions involving sex (all
F < 1.69, all P > 0.17).
Although the effects of group and testing conditions on fall fre-
quency did not interact, inspection of falls for individual testing con-
ditions (Figs. 1B–E) may assist the interpretation of the main
finding. Notably, falls elicited by the unfamiliar cw-rotating condi-
tion (Fig. 1D) and, subsequently, by alternating the rotation direc-
tion, appeared to have contributed to the DON + IDL treatment
effect found in the overall analysis of these data. In contrast,
treatment with DON alone did not reduce falls during cw-rotating
Table 2. Summary of main treatment effects
Test days # of trials
Main effects of treatment group or
significant group 9 test condition Multiple comparisons
Falls (percentage
of trials with falls)
2, 3, 4, 5 24 Group: F4,60 = 2.62, P = 0.04 SH/VEH less falls than DL/VEH and DL/IDL*
DL/DON + IDL less falls than DL/VEH*
Traversal time 2, 3, 4, 5 24 Group: F4,60 = 3.31, P = 0.02 DL/IDL slower than all other groups
(** vs. SH/VEH; * vs. all other groups)
Slips 2, 3, 4, 5 24 Group: F4,60 = 2.37, P = 0.06 (n.s.) N/A
Falls with doorframe distractor 6, 7, 11 12 Group 9 condition: F4,60 = 3.15, P = 0.02 SH/VEH less door falls than DL/VEH*,
DL/DON*, & DL/IDL*.
DL/DON + IDL less falls than DL/IDL*
Active distractor task:
retrievals without falling
8, 9, 10, 12 28 Group: F4,60 = 5.84, P < 0.001 SH/VEH more retrievals without falling than
all other groups**
*P < 0.05; **P < 0.01.
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Fig. 1. Falls during rod traversal (N = 70, n = 14 per group and 7/sex). Across all testing conditions, DL rats fell more frequently than SH/VEH rats. Further-
more, compared with DL/VEH rats, treatment with DON + IDL significantly lowered fall rates (A). Inspection of individual testing conditions (B–E) indicated
that reduction of falls associated with traversing the rod rotating in the unfamiliar clockwise (cw) direction and alternatively rotating in the cw and counterclock-
wise (cc) directions contributed primarily to the overall effect of DON + ILA in DL rats. This and the following figures indicate the results of post hoc multiple
comparisons that were based on significant results from ANOVAs that are described in Results (*,**,***, P < 0.05, 0.01, 0.001; abbreviations used in this and
other figures: SH, sham-operated; DL, dual basal forebrain cholinergic and striatal dopaminergic lesions; DON, donepezil, IDL, idalopirdine). [Colour figure can
be viewed at wileyonlinelibrary.com].
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rod as traversals (Fig. 1D) and therefore did not significantly ame-
liorate the overall fall rate of DL rats.
Traversal speed
Similar to the effects on falls, traversal speed differed between
groups (F4,60 = 3.31, P = 0.02), with the treatment group that fell
as often as vehicle-treated DL rats, DL/IDL, exhibiting the slowest
traversals (SH/VEH: 3.96  0.19 s; DL/VEH: 4.62  0.25 s;
DL/DON: 4.48  0.36 s; DL/IDL: 5.48  0.45 s, DL/DON + IDL:
4.58  0.32 s; DL/IDL significantly slower than all other groups).
Moreover, males were generally slower than females (F1,60 = 13.54,
P = 0.001; males: 5.12  0.23 s, females: 4.13  0.17 s; see Meth-
ods for greater body weights of males). In either sex, body weights
were not correlated with traversal speeds (both R2 < 0.06). Traversal
speed was not affected by testing condition and no two- or three-
way interactions between the three factors were found (all
(F < 0.91, p > 0.33).
Slips
Traversing rotating rods generally caused more slips compared with
the stationary rod (F3,180 = 37.53, P < 0.001; stationary:
1.02  0.67 slips; cc: 2.31  0.16; cw: 2.39  0.15; alternating:
2.35  0.13). The number of slips did not differ among groups
(F4,60 = 2.37, P = 0.06), with the trend reflecting that DL/IDL rats
appeared to slip more frequently than all other DL rats (SH/VEH:
1.60 + 0.11; DL/VEH: 2.04 + 0.16; DL/DON: 2.04 + 0.14;
DL/IDL: 2.51 + 0.38, DL/DON + IDL: 1.92 + 0.16). Males slipped
more often than females (F1,60 = 5.64, P = 0.02; males:
2.24  0.17; females: 1.79  0.10) but once again there were no
interactions between the three factors (all F < 1.01, p > 0.44). Slips
in males, but not females were positively correlated with their body
weights (males: R2 = 0.14, P = 0.03; females: R2 = 0.08, P = 0.10).
DON + IDL-treated DL rats are protected against doorframe-
associated falls
In PD patients who already have a propensity for freezing of gait,
tight doorways are highly effective in evoking freezing and thus
increasing the risk for falls (Cowie et al., 2012). This effect is
hypothesized to reflect a shift of limited attentional resources away
from supporting forward movement to the processing of this distrac-
tor. The doorframe distractor (see illustration in Fig. 2A) was placed
along the rod on test days 6, 7, and 11. On days 6 and 7, the door-
frame was presented three times in six trials and six times in 10 tri-
als on day 11. In total, there were 12 presentations of the doorframe
and 10 non-doorframe trials. The direction of rotating rod was alter-
nated between cc and cw directions for these trials.
Overall, the door distractor more than tripled the percentage of tri-
als in which falls occurred (F1,60 = 117.10, P < 0.001; door falls:
38.34  2.89%, non-door falls: 11.30  1.34%). The main effect of
group (F4,60 = 3.24, P = 0.018) and a significant door x group
interaction (F4,60 = 3.15, P = 0.02) reflected that doorframe-evoked
falls accounted for the group differences (Fig. 2B). DL rats treated
either with VEH, DON, or IDL experienced more doorframe-asso-
ciated falls than SH/VEH rats. In contrast, in the presence of the
doorframe, fall rates in DL/DON + IDL rats did not differ from
those in SH/VEH rats and were significantly lower than fall rates in
DL/IDL rats (Cohen’s d = 0.74; Fig. 2B). In all rats, the rate of
doorframe-associated falls decreased across the three testing days
(main effect of day: F1,120 = 48.31, P < 0.001; day 1:
64.76  4.42% falls, 2: 38.10  4.14%, 3: 12.14  2.14; all inter-
actions with other factors: F < 1.34, P > 0.23).
The doorframe caused almost twice as many falls in males than
females; however, males did not fall more than females in the
absence of the doorframe (sex x condition: F1,60 = 34.24,
P < 0.001; percentage of door falls over trials; females:
25.69  3.76%, males: 50.99  3.22%, t(69) = 26.09, P < 0.001;
non-door falls females: 13.27  1.81%, males: 9.32  1.95%,
t(69) = 2.20, P = 0.14). Doorframe-associated falls in males did not
correlate with their body weights or traversal speeds (both
R2 < 0.03). However, slower females had more falls in this condi-
tion (R2 = 0.21, P = 0.005). There were no significant interactions
between the three factors (all F < 1.31, all P > 0.25).
Microbehavioral correlates of doorframe falls and treatment
effects
To explore potential behavioral correlates of the DON + IDL treat-
ment effect on doorframe-associated falls, a video-based analysis of
the animals’ microbehavior during doorframe traversal was con-
ducted. To optimize the potential insights gained from this analysis,
we selected doorframe runs from DL/VEH and DL/DON + IDL
male and female rats from days when their fall rates reflected their
group means (days 6 and 7 for females, and 11 for males). In gen-
eral, we observed that the rats of both groups stopped forward
movement when approaching the doorframe (effects of groups on
freezing duration: F1,27 = 1.22, P = 0.28; DL/VEH: 1.25  0.22
s/freeze; DL/DON + IDL: 0.93  0.21 s). Furthermore, the individ-
ual rats’ duration of freezing periods correlated with their fall rates
(Fig. 2C). Because we observed that longer freezes nearly consis-
tently were associated with falls in all rats, doorframe-evoked
freezes were grouped into long (≥ 2 s) vs. short freezes (< 2 s). The
percentage of trials in which a long freeze occurred did not differ
between the two groups (six trials per animal; F1,27 = 2.59,
P = 0.12; 26.79  4.95% of trials involved long freezes). In addi-
tion, rates of falls associated with long freezes – in animals that dis-
played at least one such freeze (10 DL/VEH and 9
DL/DON + IDL) – did not differ between these two groups
(F1,18 = 0.004, P = 0.95; DL/VEH: 62.67  12.62% falls in runs
involving long doorframe-associated freezes; DL/DON + IDL:
63.89  13.89%). However, fall rates associated with short freezes
were higher in DL/VEH than the DL/DON + IDL rats (14 rats per
group; F1,27 = 5.27, P = 0.03, Fig 2D). Thus, these observations
indicated that treating DL rats with DON + IDL did not increase
the proportion of doorframe runs that were associated with relatively
short freezes, but DON + IDL-treated rats were more capable of
resuming and continuing the traversal after short freezes, perhaps by
better maintaining or recovering posture and balance, and re-
initiating forward movement than was the case for DL/VEH rats.
To further detail the potential effects of the combined treatment
with DON + IDL, we selected representative runs (first two trials on
doorframe day 2 in females and on day 3 for males; two trials per rat)
and counted the rate of the following behaviors for a 1-s period begin-
ning shortly after and during short freezes (0.5–1.5 s of freezing peri-
ods): (i) sudden increases of traversal speed after a freeze; (ii) high
and firm tail position while passing under the doorframe (associated
with controlled, upright posture and forward focus in contrast to a
low, dragging tail and slouched posture and downward focus typical
of DL rats; Kucinski et al., 2013); (iii) swinging of the tail to maintain
balance following doorframe-associated slips; (iv) the use of forelimbs
to ‘push’ the upper trunk of the body back onto the rod after slips; (v)
active hind limb movements (‘walking in place’) during freezes to
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Fig. 2. Effects of the doorframe distractor (N = 70, n = 14 per group and 7/sex). All DL rats, except for DL/DON+IDL rats, fell more frequently than SH/VEH rats
when exposed to this passive distractor (A and B). To gain insight into potential behavioral mechanisms mediating the effects of DON+IDL, the doorframe-asso-
ciated behavior of DL/VEH and DL/DON + IDL rats was further analyzed. Doorframe-associated falls were associated with stoppage of movement or freezing of
gait, as rats approached or reached the frame. Generally, longer freezes were associated with more falls (C) in both DL/VEH and DL/DON + IDL rats. Indeed, falls
associated with longer freezes did not differ between the groups (D). However, DON + IDL-treated rats fell significantly less frequently when freezes remained rela-
tively short (< 2 s). The proportion of short freezes itself did not differ between the groups. As illustrated in E (see Results for quantification), following short
freezes, and even if they did not fall, DL/VEH rats resumed forward movement relatively slowly, generally with the tail positioned relatively low and with a
slouched posture (note that this rat slips after passing through the door). In contrast, when DL/DON + IDL rats resumed forward movement, sometimes starting with
a hop (as shown here), they quickly regaining regular traversal speed and fluid forward movement, with high and firm tail position and upright posture. [Colour fig-
ure can be viewed at wileyonlinelibrary.com].
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maintain balance on the rod; and (vi) small ‘hops’ after freezes to
reestablish forward momentum through the doorframe. Results indi-
cate that, first, a composite score collapsing counts of all six behaviors
negatively correlated with fall rates in both groups (both R2 > 0.42,
both P < 0.02), indicating that active recovery movements following
short freezes are a strong predictors of successful doorframe runs.
Second, DL/DON + IDL rats exhibited more instances of category #2
behavior (above) than DL/VEH rats (X2 = 7.22, P = 0.03, DL/VEH:
0.18  0.10 counts/trial, DL/DON + IDL: 0.54  0.11; all other cat-
egories of behavior: P > 0.30; Figs. 2E). Together, these observations
suggest that DON + IDL treatment fosters the maintenance and, after
relatively short stoppages, facilitates the recovery of posture, balance,
and forward movement.
DON + IDL-treated DL rats are not protected against active
distractor-associated falls
Falls in aged humans and PD patients are correlated with poor dual
task performance (Shumway-Cook et al., 1997; Marchese et al.,
2003; Amboni et al., 2013). To model the impact of the reallocation
of attentional resources to a secondary task on complex movement
control, water-deprived rats were offered water for retrieval while
traversing the rotating rod. In total, there were 28 runs with water
being offered (see Methods and Table 1).
Overall, 54 of the 70 (77.14%) animals retrieved water (defined
as licking water for at least 1 s, regardless of falls) in at least one
trial (13 SH/VEH, 9 DL/VEH, 10 DL/DON, 11 DL/IDL, and 11
DL/DON + IDL; 26 males and 28 females). A main effect of group
indicated that all DL rats retrieved water less frequently than
SH/VEH rats (F4,60 = 3.32, P = 0.016), although multiple compar-
isons indicated that DL/DON rats’ retrieval count was not signifi-
cantly lower than DL/VEH (Fig. 3A). Females retrieved water more
frequently than males (F1,60 = 10.56, P = 0.002; females:
49.78  6.32%, males: 26.69  4.36%); however, the effects of
sex did not interact with group (F4,60 = 1.50, P = 0.22). In this test,
water retrievals and falls are confounded measures as stopping for-
ward movement to retrieve water is a high risk for falls. SD/VEH
rats succeeded more frequently in retrieving water without falling
than DL rats (F4,60 = 5.84, P < 0.001; Fig. 3B). Furthermore,
females successfully retrieved water without falling more frequently
than males (F1,60 = 10.81, P = 0.002; females 33.98 + 5.02% of tri-
als; males: 16.73 + 3.36%) but this effect did not interact with
group (F1,69 = 1.56, P = 0.19). In neither sex did this measure cor-
relate with body weights, traversal speed, or doorframe-associated
falls (all R2 < 0.1). Thus, DL lesions reduced the engagement with
the active distractor and elevated associated falls and the drug treat-
ments did not benefit rod traversal performance in the presence of
this active distractor.
Lesion-induced impairment in sustained attention task
performance and lack of treatment effects
As detailed in Methods, following the completion of the post-surgery
recovery period of 4 weeks, animals were returned to morning SAT
and afternoon MCMCT testing, and drug treatments were adminis-
tered 30 min prior to the morning as well as the afternoon test session.
The analysis of post-surgery SAT performance was based on the data
from the final five SAT sessions (averaged for individual rats). Overall
SAT performance, as indicated by SAT scores, was impaired in all
lesioned groups when compared with SH/VEH rats (main effect of
group: F4,60 = 3.38, P = 0.015; SH/VEH: 0.33  0.02; DL/VEH:
0.18  0.04; DL/DON: 0.23  0.04; DL/IDL: 0.19  0.03;
DL/DON + IDL: 0.19  0.03; SH/VEH had higher score than all
other groups, all P < 0.05, no other group differences).
In addition to the main effect of drug group on SAT scores, there
was a significant interaction between the effects of group and signal
duration (main effect of signal duration: F2,138 = 272.98, P < 0.001;
group 9 signal: F8,120 = 4.59, P < 0.001; Fig. 4A). To identify the
locus of this interaction, one-way ANOVAs on the effects of group
were computed for the SAT scores for individual signal durations
and followed up, if applicable, by multiple comparisons (see
Fig. 4A). SH/VEH rats had higher scores than all other groups with
respect to longest signals (F4,60 = 5.36, P = 0.001) and higher scores
than DL/VEH and DL/IDL rats for medium duration signals. SAT
scores calculated over hits to shortest signals were relatively low
across groups (Fig. 4A), thus probably preventing the manifestation
Fig. 3. Performance on active distractor task (N = 70, n = 14 per group and
7/sex). To model the impact of a secondary task, water was offered as rats
traversed the rotating rod (see top photograph; rats were water-deprived
because of the parallel, daily SAT testing). DL rats were generally less likely
to engage in this competing activity as indicated by lower number of
attempts to retrieve the water (A). DL rats were also less likely to retrieve
water without incurring a fall (B). The drug treatments did not significantly
improve the performance of DL rats in the presence of this active distractor.
[Colour figure can be viewed at wileyonlinelibrary.com].
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of the effects of lesions on these measures. Similar to pre-surgery
SAT performance, there were no sex effects and no interactions
involving sex, group, or signal duration (all F < 1.51, all P > 0.21).
The results of the analysis of hits partly mirrored the findings on
SAT scores, indicating that SAT score group differences primarily
reflected the effects of lesions on hits (main effect of group:
F4,60 = 0.61, P = 0.66; main effect of signal duration: F2,138 = 197.90,
P < 0.001; group 9 signal: F8,120 = 4.44, P < 0.001; Fig 4B). Three
out of the four DL groups scored less hits to longest signals than SH/
VEH (one-way ANOVA on effects of group on hits to 500 ms signals:
F4,60 = 2.93, P = 0.028). Hit rates to shorter signals did not differ
between groups (both F < 0.42, both P > 0.79). Finally, neither correct
rejections (Fig. 4C) nor errors of omission differed between groups
(both F < 2.23, both P > 0.08; Fig. 4D), and there were no effects of
sex (all main effects and interactions: all F < 1.29, all P > 0.14).
Together, these findings reproduce the effects of DL lesions on SAT
performance (Kucinski et al., 2013), with the loss of cholinergic neu-
rons likely being primarily responsible for the decrease in hits
(McGaughy et al., 1996). However, none of the DL rats treated with
DON, IDL or the two drugs combined showed improved performance
compared with DL/VEH rats.
Histological analyses
Semi-quantitative cholinergic cell density estimates in the basal fore-
brain indicated that the lesions removed about 60–70% of the
cholinergic cell bodies in the rostral nucleus basalis of Meynert (nbM)
and about 50% of the cholinergic neurons in the more ventral horizon-
tal nucleus of the diagonal band (HDM; Fig. 5). Such a partial loss
was intended to model the limited cholinergic losses in non-demented
PD fallers (Bohnen et al., 2009) and it is also reflected in the limited
severity of the impairments in SAT performance (Fig. 4). In the analy-
sis of cholinergic losses in both BF subregions, main effects of group
(both F4,59 > 4.34, both P < 0.005) indicated a lower number of
cholinergic cells in all DL rat groups, with no differences among DL
groups (Fig. 5). Cholinergic losses did not differ by sex and there
were no sex 9 group interactions (all F < 2.08, all P > 0.10).
Striatal dopamine depletions were rated based on size (mean
score: 4.13  0.28) and the intensity of TH-immunoreactivity losses
(5.33  0.21; see Methods). Scores did not differ between the
groups or sexes (main effects and interactions: all F < 0.81; all
P > 0.37). We further investigated whether cholinergic or dopamin-
ergic lesion scores correlated with the propensity for falls in
DL/VEH or DL/DON + IDL rats and found only one relationship
that indicates that in treated DL rats, falls were lower in rats with
larger striatal dopamine lesions (Fig. 5F; all other groups: all
R2 < 0.20, all P > 0.17).
Discussion
We tested the effects of donepezil (DON) and idalopirdine (IDL) in
rats with cortical cholinergic and striatal dopaminergic losses (DL
Fig. 4. SAT performance (N = 70, n = 14 per group and 7/sex). Overall SAT performance, indicated by SAT scores, was lower in all rats with DL lesions
(main effect). Moreover, a significant interaction between the effects of group and signal duration (A) reflected that “floor effects” limited the impact of the DL
lesions on SAT scores calculated over hits to shorter signals. The effects of the lesions on overall performance were largely reproduced in the analyses of hits
(B) while, similar to prior studies on the effects of DL lesions or solely lesions of the cortical cholinergic inputs system, correct rejections (C) and errors of
omission (D) remained unaffected. The drug treatments did not improve SAT performance of DL rats (in A, DL/VEH vs. DL/DON: P = 0.40). [Colour figure
can be viewed at wileyonlinelibrary.com].
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rats) traversing rotating rods and performing the sustained attention
task (SAT). (i) Co-treatment with DON + IDL reduced falls on the
rotating rod as well as falls evoked by the doorframe distractor. (ii)
DON + IDL prevented falls primarily by enhancing the efficacy and
vigor of the re-initiation of rotating rod traversal following relatively
brief movement stoppages. (iii) Falls evoked by the active distractor/
dual task were not affected by the treatment. (iv) SAT performance
did not benefit from DON + IDL treatment. (v) Neither DON nor
IDL significantly improved SAT or MCMCT performance when
administered alone. (vi) DON + IDL was more effective in rats with
relatively larger dopamine depletions.
Previous evidence rejects the possibility that the present effects of
DON + IDL were based on pharmacokinetic interactions between
the two drugs (Herrik et al., 2016). Furthermore, it seems unlikely
that the contrast between effects of DON + IDL on MCMCT per-
formance, assessed following the afternoon administration of the
compounds, and the absence of effects on SAT performance,
assessed following the morning administration of the compounds,
was due to the relatively shorter delay between the morning and the
afternoon injections (6 h). DON + IDL-induced increases in basal
extracellular acetylcholine (ACh) levels, measured by microdialysis,





Fig. 5. Histological analyses and relationship with treatment effects. Semi-quantitative counts of cholinergic neurons in the nucleus basalis of Meynert (nbM) and
the horizontal nucleus of the diagonal band (HDB; schematically illustrated in A) indicated lesion-induced losses ranging from 60 to 70% in the nbM (B) to about
50% in the HDB (C; M; SEM; see Results for statistical analyses). (D) (AP from bregma: 0.8 mm) and E (AP: 0.10 mm) are coronal sections showing ChAT-
immunoreactive neurons in the BF of a sham-operated rat (D) and an immunotoxin-infused rat (E) (bars: 0.5 mm; m depicts the midline of the brain). (F) Correla-
tions between dopaminergic lesion scores and falls by DL/DON + IDL rats (F; R2 = 0.34, P = 0.03; note that the correlation remains significant following the
removal of data from the animal with the highest fall rate; R2 = 0.38, P = 0.022). This correlation suggests that DON + IDL was more effective at reducing falls
in rats with larger striatal dopamine depletions. (G) and (H) show examples of a smaller and a large striatal dopamine lesion, respectively, and their positions in
(F) are indicated by the green and blue, respectively, halo around their data points. [Colour figure can be viewed at wileyonlinelibrary.com].
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unlikely to have carried over from the morning to the afternoon
session.
DL rats treated with DON + IDL exhibited less falls while
traversing the rotating rod than other DL groups, and they specifi-
cally fell less often in association with relatively short doorframe-
evoked stoppages. In human fallers, as in DL rats, slow gait speed
and movement stoppages, evoked by distractors or occurring without
obvious causes, destabilize forward movement and increases the risk
for falls (Springer et al., 2006; Plotnik et al., 2011). Stoppages or
freezing of gait involve both instabilities in posture and gait control
as well as disruption of movement selection and planning, and thus
such stoppages may reflect the breakdown of cortico-striatal commu-
nication, rather than solely losses of striatal dopamine (Lewis &
Barker, 2009; Vercruysse et al., 2012; Heremans et al., 2013;
Bohnen et al., 2014; Kucinski et al., 2015a).
In humans, as in DL rats, freezing episodes may occur for a cou-
ple of seconds or longer (Nutt et al., 2011). However, while
traversing dynamic surfaces, shorter stoppages allow for planned
movements to stay “online” in working memory so that motor
plans can be updated to account for surface changes and adjust-
ments of limb placements and balance, and to allow for corrections
after stepping errors (Seidler et al., 2012). Such cognitive-motor
interactions favor successful movement re-initiation after relatively
short stoppages. Indeed, traversing the rotating rod at 10 RPM and
stopping for 2 s (the upper limit of “short” stoppages in our analy-
ses) requires coping with 120° of rod rotation, including rebalanc-
ing and posture adjustments and re-placing limbs as forward
movement resumes. DL rats treated with DON + IDL were signifi-
cantly more effective in mastering this situation. After having
resumed forward movement, DL rats treated with DON + IDL
often rapidly displayed effective posture and balance control and
displayed a level of vigor of movement less frequently observed in
vehicle-treated DL rats.
Maintaining motor plans in working memory and resuming move-
ment with relatively high vigor are confounded variables and thus it
is difficult to further isolate the cognitive-behavioral mechanisms
that mediated the effects of DON + IDL. However, if the treatment
had primarily improved the vigor of movement, thought to reflect
the status of striatal dopamine systems (Mazzoni et al., 2007; Niv
et al., 2007; Wang et al., 2013; Gepshtein et al., 2014), we would
have expected that this treatment also reduced the portion of rela-
tively long stoppages. As this was not the case, enhanced vigor
alone is unlikely to account for the treatment effect. Rather, follow-
ing doorframe-evoked freezes or slips, DL rats treated with
DON + IDL may have been superior in integrating information
about the rod status, balance, and limb positioning with ongoing
movement programs, while also benefiting from greater vigor of cor-
rective movements.
Treatment with IDL was previously demonstrated to potentiate
the effect of DON on basal cortical and hippocampal extracellular
ACh levels, with no effects of IDL on ACh levels alone (Foraster
et al., 2014; Herrik et al., 2016). Relatively high levels of cortical
cholinergic neuromodulation may benefit SAT performance when
challenged by distractors (St Peters et al., 2011) and, in DL rats,
about half of the cholinergic systems remained intact and thus might
have supported treatment-induced increases in extracellular ACh
levels. However, neither DON alone nor in combination with IDL
improved SAT performance. Although the effects of these treat-
ments on cortical ACh levels in this model remain unknown, the
absence of treatment effects on SAT performance suggests that cor-
tical pro-cholinergic/pro-attentional mechanisms do not sufficiently
explain the reduction in falls in DON + IDL-treated DL rats.
Impairments in SAT performance in DL rats largely reflect their
cholinergic losses. In contrast, rats with lesions of only the BF or
only the dopaminergic striatum, with one minor exception, were not
significantly impaired in the MCMCT (Kucinski et al., 2013). Thus,
in contrast to SAT impairments, impaired MCMCT performance
requires interactions between cholinergic-attentional deficits and stri-
atal-motor deficits. Consequently, the effects of DON + IDL treat-
ment may have acted at the intersection between these two systems.
BF cholinergic lesions or optogenetic silencing of cholinergic neu-
rons disrupt a complex cognitive process that allows a cue to control
behavior (Sarter et al., 2014b, 2016; Gritton et al., 2016) and thus
impair the cortico-striatal, glutamatergic transfer of information
about external and proprioceptive cues that normally assists balance,
gait, and movement control (see Fig. 2 in Sarter et al., 2014a). Such
cue-related information may be transferred specifically to synapses
on dendritic spines of medium spiny neurons (Dube et al., 1988) of
direct-pathway projections (Wall et al., 2013). Cortico-striatal sig-
naling is modulated by D1 receptors expressed on the neck of the
spines that are also contacted by cortico-striatal projections (Pickel
et al., 1981) and thus, in DL rats, both cortico-striatal signaling and
the dopaminergic modulation of such signaling may be disrupted.
The predominant expression of 5-HT6 receptors on pyramidal neu-
rons throughout the cortex and in basal ganglia output neurons, and
their co-localization with striatal dopamine receptors (Helboe et al.,
2015), are consistent with the speculation that the treatment restored,
to a degree, such cortico-striatal, glutamatergic–dopaminergic inter-
actions. The neuropharmacological interactions between DON and
IDL on striatal output neurons is not clear and may involve diverse
signaling pathways converging onto striatal output neurons (e.g.,
Yan & Surmeier, 1996; Threlfell et al., 2012; Nelson et al., 2014).
In functional terms, elevation of striatal-cholinergic interneuronal
activity may have interacted with 5-HT6 receptor blockade to main-
tain movement plans during short stoppages and thus maintained
goal-directed behavior (e.g., Bradfield et al., 2013; Aoki et al.,
2015). The absence of treatment effects on SAT performance and
on falls evoked by the active water distractor is also consistent with
the possibility that DON + IDL reduced fall propensity by partly
restoring cognitive-motor interactions that, in cognitive terms, may
be downstream from effects on the attentional control of movement.
Such downstream effects may remain mediated via synergistic
effects of DON + IDL on telencephalic circuitry (Foraster et al.,
2014; Herrik et al., 2016). However, in addition to potential effects
on DON + IDL on telencephalic-striatal circuitry, this treatment may
enhance the functions of brainstem ascending cholinergic systems also
thought to be involved in movement control (e.g., Kucinski & Sarter,
2015). The simultaneous measurement of striatal ACh, amino acids
and monoamines in DL rats traversing the rotating rod and treated
with DON + IDL may be a first future step toward identifying rele-
vant neuropharmacological interactions between the two drugs.
Finally, the current experiment indicated that males generally
performed poorer across the more demanding MCMCT conditions
than females, and that, with one exception, the greater body weight
of males did not seem to account for this sex effect. Similar sex
effects have been observed in humans (Pereira et al., 2013) and, as
in the current DL rats, their neuronal or behavioral origins are
unclear. Importantly, however, in the present study, treatment
effects did not differ by sex. As SAT performance did not differ
between the sexes (see also McGaughy & Sarter, 1999) but as
females retrieved water without falling more frequently than males,
greater dual task capacity in females may be a primary mediator of
their relatively better MCMCT performance (see also Hollman
et al., 2011).
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Conclusions
The present evidence indicates the efficacy of treatment with
DON + IDL in reducing falls in DL rats and thus may form the
basis for predictions regarding the clinical efficacy of this combina-
tion treatment. However, it is important to first acknowledge that
DL rats do not constitute a model of PD; rather, DL rats are a
hypothesis-driven animal model of impaired cortico-striatal interac-
tions hypothesized to underlie falls. As we previously demonstrated
(Kucinski et al., 2013), DL rats lack the primary motor and sensor-
motor deficits that characterize rats with relatively larger uni- or
bilateral striatal dopamine depletions (for review see Deumens et al.,
2002). Indeed, the presence of such deficits would severely con-
found interpretations in terms of cognitive-motor interactions under-
lying falls in this model.
Our results in DL rats suggest that the co- treatment with an
acetylcholinesterase inhibitor and a 5-HT6 receptor antagonist may
reduce the fall propensity in PD patients who also exhibit a propen-
sity for relatively brief movement stoppages evoked by distractors
or occurring spontaneously. This treatment may be less effective in
more severely impaired PD fallers who exhibit longer periods of
freezing of gait (Lewis & Barker, 2009; Vercruysse et al., 2012).
Finally, considering that in the present experiment rats continued
daily traversal practice while undergoing pharmacological treatment,
the clinical efficacy of the present pharmacological combination
treatment may be enhanced based on interactions with parallel
behavioral programs aimed at reducing falls.
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